|
RNF146 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.186800E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.023800E-01 |
| Normal-vs-Stage2 |
5.821900E-02 |
| Normal-vs-Stage3 |
4.33099999996855E-06 |
| Normal-vs-Stage4 |
5.20089999955786E-08 |
| Stage1-vs-Stage2 |
1.699390E-01 |
| Stage1-vs-Stage3 |
6.010700E-04 |
| Stage1-vs-Stage4 |
3.51690000000016E-06 |
| Stage2-vs-Stage3 |
3.602800E-01 |
| Stage2-vs-Stage4 |
1.251180E-01 |
| Stage3-vs-Stage4 |
3.641000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.30329999999701E-05 |
| Normal-vs-AfricanAmerican |
6.505400E-01 |
| Normal-vs-Asian |
7.725200E-01 |
| Caucasian-vs-AfricanAmerican |
5.166300E-02 |
| Caucasian-vs-Asian |
1.735440E-01 |
| AfricanAmerican-vs-Asian |
5.949600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.57360000000639E-05 |
| Normal-vs-Female |
6.379700E-02 |
| Male-vs-Female |
3.328200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.066200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.075700E-02 |
| Normal-vs-Age(61-80Yrs) |
1.72982999999682E-05 |
| Normal-vs-Age(81-100Yrs) |
5.903700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.804600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.906600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.091400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.326500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.779400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.812200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.618600E-03 |
| Normal-vs-Grade 2 |
5.032200E-01 |
| Normal-vs-Grade 3 |
8.5481000000609E-07 |
| Normal-vs-Grade 4 |
1.07830000484199E-09 |
| Grade 1-vs-Grade 2 |
7.144300E-03 |
| Grade 1-vs-Grade 3 |
1.445190E-04 |
| Grade 1-vs-Grade 4 |
7.05649999988012E-07 |
| Grade 2-vs-Grade 3 |
5.66349999999716E-05 |
| Grade 2-vs-Grade 4 |
2.02519999659145E-08 |
| Grade 3-vs-Grade 4 |
7.624600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.091000E-01 |
| Normal-vs-ccB subtype |
1.54940005270277E-09 |
| ccA subtype-vs-ccB subtype |
4.2097991759249E-11 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.082210E-02 |
| Normal-vs-N1 |
1.044220E-02 |
| N0-vs-N1 |
2.763700E-02 |
|
|
